The emergence of Marburg virus (MARV) in Guinea and Ghana triggered the assembly of the
MARV vaccine “MARVAC” consortium representing leaders in the field of vaccine research …

Marburg virus (MARV) is a virus of high human consequence with a case fatality rate of 24–88%.
The global health and national security risks posed by Marburg virus disease (MVD) …

… at MedImmune; Tim Schofield is the director of US regulatory affairs at GlaxoSmithKline;
Samantha Sheridan is the director of regulatory affairs at Shire Pharmaceuticals; Paul Smock is …

We evaluated the performance of the Du Pont aca ammonia procedure with regard to (a)
linearity, (b) precision, (c) interferences, and (d) effect of anticoagulants. Linearity extends to …

… at MedImmune; Tim Schofield is the director of US regulatory affairs at GlaxoSmithKline;
Samantha Sheridan is the director of regulatory affairs at Shire Pharmaceuticals; Paul Smock is …

… This dissertation, by Paul L. Smock, is accepted in its present form by the Department of Child
Development and Family Relationships of Brigham Young University as satisfying the thesis …

… ), PAUL SMOCK (MERIDIAN BIOGROUP LLC AND WAS EMPLOYED BY ASTRAZENECA
AT THE TIME THE WORK WAS COMPLETED), ROBIN PAYNE (BPOG FACILITATOR), TIM …

A novel system for determining blood ammonia concentrations in the clinically significant
range, 0 to 300 ug/dl, has been developed using basic techniques evolved at Monsanto …

The ‘aca’ system comprises an automatic clinical analyzer (‘aca’) and a repertoire of analytical
methods for performing a variety of discrete chemical analyses of body fluid samples. …

… at MedImmune; Tim Schofield is the director of US regulatory affairs at GlaxoSmithKline;
Samantha Sheridan is the director of regulatory affairs at Shire Pharmaceuticals; Paul Smock is …